Close
Almac
Achema middle east

UHPT Method In NMR Benefits Natural Product Bio Industry

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio

AstraZeneca has gone ahead and committed $100 million to...

Laboratory Equipment Outsourcing Through CDMOs: Strategic and Cost Implications

Outsourcing laboratory infrastructure to CDMOs offers pharma companies critical agility, transforming fixed capital costs into flexible operational expenses while accessing cutting-edge technology like Cryo-EM.

Specialized Laboratory Equipment Requirements for Biologics and Biosimilar Development

The development of complex biological molecules requires a specialized toolkit distinct from traditional small-molecule chemistry. This article details the critical laboratory equipment—from advanced bioreactors to high-resolution characterization tools—that enables the precise engineering and rigorous analysis required for successful biologics and biosimilar innovation.
- Advertisement -

In the late 1950s and 1960s, thalidomide, a drug given to pregnant women to alleviate morning sickness, caused a tragic outcome. Over 12,000 babies were born with severe malformations, like shortened limbs, due to the drug’s side effects. These deformities were caused by the drug’s racemic mixture of two mirror-image forms. Understanding the molecular structures of compounds is vital for comprehending biological processes and developing effective drugs. Nuclear magnetic resonance spectroscopy (NMR) plays a significant role in this research by interpreting frequency signals. However, until recently, selectively measuring carbon nuclei signals associated with specific hydrogen atoms in a single measurement posed a challenge.

However, there is good news. Doctors in Korea have introduced a groundbreaking NMR method called the ultraselective heteronuclear polarization transfer method (UHPT). Before the UHPT method, NMR equipment allowed for selective measurement of specific hydrogen nuclei signals but lacked rapid measurement of carbon nuclei signals, leading to unsatisfactory resolution of hydrogen-carbon NMR signals. Additionally, it hindered the identification of chemical structures in pharmaceutical raw materials and potentially toxic drugs.

Thanks to the UHPT method, the doctors successfully distinguished carbon nuclei associated with specific hydrogen atom nuclei in a single measurement, even amid complex carbon-carbon NMR signals, achieving a signal resolution of several hertz (Hz). They used this method to analyze the structures of complex natural products like the anticancer drug dactinomycin, which comprises optical isomers of amino acids, and accurately assign the structure of the fungicide iprovicarb, a mixture of diastereoisomers.

This novel method is not only faster and more accurate than conventional approaches but also economically efficient. The UHPT method significantly reduces the measurement time needed for ultra-high field NMR equipment, achieving equivalent NMR signal resolution approximately one-fifth of the time.

As per insights, this new NMR method can become a standard analysis technique for identifying and standardizing active ingredients in the natural product bio industry. By using this method to identify the structure of partial particulate matter, which plays a crucial role when it comes to determining the efficacy and safety of drugs, it is expected to contribute significantly to the development of the natural product bio industry and address challenges in drug development processes.

Latest stories

Related stories

AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio

AstraZeneca has gone ahead and committed $100 million to...

Laboratory Equipment Outsourcing Through CDMOs: Strategic and Cost Implications

Outsourcing laboratory infrastructure to CDMOs offers pharma companies critical agility, transforming fixed capital costs into flexible operational expenses while accessing cutting-edge technology like Cryo-EM.

Specialized Laboratory Equipment Requirements for Biologics and Biosimilar Development

The development of complex biological molecules requires a specialized toolkit distinct from traditional small-molecule chemistry. This article details the critical laboratory equipment—from advanced bioreactors to high-resolution characterization tools—that enables the precise engineering and rigorous analysis required for successful biologics and biosimilar innovation.

Next-Generation Laboratory Equipment Redefining Drug Discovery Workflows

Advanced technologies such as AI-integrated high-throughput screening platforms and automated assay systems are fundamentally transforming early-stage pharmaceutical research. These innovations address critical bottlenecks in productivity and data quality, enabling research teams to accelerate timeline-to-candidate selection while enhancing the predictive accuracy of drug discovery campaigns.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »